Login
$UVV
$39.56 +$0.60 (1.54%) Close

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts
Q1 FY2027
As of Jun 30, 2026
Q4 FY2026
As of Mar 31, 2026
Q3 FY2026
As of Dec 31, 2025
Q2 FY2026
As of Sep 30, 2025
Q1 FY2026
As of Jun 30, 2025
Q4 FY2025
As of Mar 31, 2025
Q3 FY2025
As of Dec 31, 2024
Q2 FY2025
As of Sep 30, 2024
Q1 FY2025
As of Jun 30, 2024
Q4 FY2024
As of Mar 31, 2024
Q3 FY2024
As of Dec 31, 2023
Q2 FY2024
As of Sep 30, 2023
Q1 FY2024
As of Jun 30, 2023
Q4 FY2023
As of Mar 31, 2023
Q3 FY2023
As of Dec 31, 2022
Q2 FY2023
As of Sep 30, 2022
Q1 FY2023
As of Jun 30, 2022
Q4 FY2022
As of Mar 31, 2022
Q3 FY2022
As of Dec 31, 2021
Q2 FY2022
As of Sep 30, 2021
ASSETS
Cash and cash equivalents
Accounts receivable, net
Advances to suppliers, net
Accounts receivable, unconsolidated affiliates
Inventories—at lower of cost or net realizable value:
Tobacco
Other Non-Tobacco Inventory
Prepaid income taxes
Other current assets
Total current assets
Property, plant and equipment
Land
Buildings
Machinery and equipment
Total property, plant and equipment
Less accumulated depreciation
Property, plant and equipment, net
Other assets
Operating lease right-of-use assets
Goodwill, net
Other intangibles, net
Investments in unconsolidated affiliates
Deferred income taxes
Pension asset
Other noncurrent assets
Total other assets
Total other assets
Total assets
LIABILITIES AND SHAREHOLDERS' EQUITY
Notes payable and overdrafts
Accounts payable
Accounts payable—unconsolidated affiliates
Customer advances and deposits
Accrued compensation
Income taxes payable
Current portion of operating lease liabilities
Accrued expenses and other current liabilities
Current portion of long-term debt
Total current liabilities
Long-term debt
Pensions and other postretirement benefits
Long-term operating lease liabilities
Other long-term liabilities
Deferred income taxes
Total liabilities
Shareholders' equity
Series A Junior Participating Preferred Stock, no par value, 500,000 shares authorized, none issued or outstanding
Common stock, no par value, 100,000,000 shares authorized 24,938,259 shares issued and outstanding at June 30, 2026 (24,807,613 at June 30, 2025 and 24,923,496 at March 31, 2026)
Retained earnings
Accumulated other comprehensive loss
Total Universal Corporation shareholders' equity
Noncontrolling interests in subsidiaries
Total shareholders' equity
Total liabilities and shareholders' equity
Preferred Stock, Shares Authorized
Preferred stock, shares outstanding
Common Stock, Shares Authorized
Common Stock, Shares, Issued
Common Stock, Shares, Outstanding

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support